BM group | VM group | Noninfected control group | |
---|---|---|---|
Gender | |||
Female | 6 | 7 | 10 |
Male | 14 | 15 | 10 |
Age (months) | |||
Median (range) | 0.25 (0.083–12.75) | 6.5 (0.5–12.83) | 1.125 (0.42–5.33) |
CSF parameters | |||
Median (range) | |||
WBC | 73 (1–344) | 30 (1–360) | 4 (0–18) |
%PMN | 0.2 (0.05–0.8) | 0.1 (0.05–0.4) | |
Glucose (mmol/L) | 2.035 (0.25–4.03) | 2.845 (2.29–4.72) | 2.91 (2.56–4.3) |
Protein (g/L) | 0.535 (0.08–1.62) | 0.165 (0.02–0.53) | 0.15 (0.03–0.29) |
Bacterial culture | |||
Blood | 6 | / | / |
CSF | 4 | / | / |
Virus | |||
PCR | 1 | 2 | / |
Virus antibody test | 7 | 16 | 5 |
Clinical characteristics | |||
Fever | 19 | 20 | 14 |
Cough | 5 | 4 | 10 |
Vomiting | 8 | 13 | 3 |
Diarrhoea | 4 | 1 | 2 |
Headache | 5 | 13 | 2 |
Meningeal irritation | 3 | 3 | 0 |